Fat Mass and Obesity Associated Gene (FTO) Expression Is Regulated Negatively by the Transcription Factor Foxa2

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Guo, Jianjin ^a   Ren, Wei ^b   Ding, Ying ^c   Li, Aimei ^c   Jia, Lu ^c   Su, Dongming ^c   Liu, Xiang ^d   Xu, Kuanfeng ^a   Yang, Tao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; LUCIFERASE; UPSTREAM STIMULATORY FACTOR;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FAT MASS AND OBESITY ASSOCIATED GENE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; PROTEINS; RNA, SMALL INTERFERING;

EID: 84870933505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051082     Document Type: Article

References (26)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, et al. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555.
2. Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, et al. (2011) The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet 12: 52.
3. Roberts DL, Dive C, Renehan AG, (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61: 301-316.
4. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
5. Do R, Bailey SD, Desbiens K, Belisle A, Montpetit A, et al. (2008) Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 57: 1147-1150.
6. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894.
7. Peng S, Zhu Y, Xu F, Ren X, Li X, et al. (2011) FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9: 71.
8. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Haring HU, et al. (2007) Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 50: 2602-2603.
9. Ng MC, Park KS, Oh B, Tam CH, Cho YM, et al. (2008) Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57: 2226-2233.
10. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, et al. (2011) FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60: 1637-1644.
11. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, et al. (2008) The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149: 2062-2071.
12. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, et al. (2009) Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol 38: 971-975.
13. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, et al. (2011) The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One 6: e16756.
14. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318: 1469-1472.
15. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, et al. (2008) Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294: R1185-1196.
16. Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, et al. (2011) FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes 60: 258-268.
17. Lantz KA, Vatamaniuk MZ, Brestelli JE, Friedman JR, Matschinsky FM, et al. (2004) Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest 114: 512-520.
18. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M, (2004) Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432: 1027-1032.
19. Silva JP, Meyenn F, Howell J, Thorens B, Wolfrum C, et al. (2009) Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 462: 646-650.
20. Olsson A, Lind L, Thornell LE, Holmberg M, (2008) Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. Hum Mol Genet 17: 1666-1672.
21. Mei H, Chen W, Srinivasan SR, Jiang F, Schork N, et al. (2010) FTO influences on longitudinal BMI over childhood and adulthood and modulation on relationship between birth weight and longitudinal BMI. Hum Genet 128: 589-596.
22. Speakman JR (2010) FTO effect on energy demand versus food intake. Nature 464: E1; discussion E2.
23. Lee CS, Friedman JR, Fulmer JT, Kaestner KH, (2005) The initiation of liver development is dependent on Foxa transcription factors. Nature 435: 944-947.
24. Tanimizu N, Miyajima A, (2007) Molecular mechanism of liver development and regeneration. Int Rev Cytol 259: 1-48.
25. Gao N, LeLay J, Vatamaniuk MZ, Rieck S, Friedman JR, et al. (2008) Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev 22: 3435-3448.
26. Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL, (2011) Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem 286: 2155-2170.